Bridge Biotherapeutics Enters into an Exclusive License Agreement with Shaperon to Strengthen Its IPF Franchise ...Middle East

The licensing deal includes an upfront payment of USD 1.63 million, and may reach up to USD 24.4 million in milestone payments and royalties By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive...

Hence then, the article about bridge biotherapeutics enters into an exclusive license agreement with shaperon to strengthen its ipf franchise was published today ( Tuesday 19/04/2022 - 04:49 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bridge Biotherapeutics Enters into an Exclusive License Agreement with Shaperon to Strengthen Its IPF Franchise )

Also on site :

• Britney Spears Spends Time With Diane Warren and Molly Shannon After DUI
• 'You should resign': Mamata hits out at PM Modi's silence on Pakistan's threat to strike Kolkata
• This Guitarist Helped Shape One of the Most Iconic Sounds of the '90s